Artigo - Atena Editora

Artigo

Baixe agora

Livros

RIFAMPICIN-RESISTANT PERICARDIAL TUBERCULOSIS ASSOCIATED WITH LUNG CANCER

Purpose: to report a case of Rifampicin-resistant Pericardial Tuberculosis with concomitant diagnosis of bronchogenic CA in a patient with no history of immunodeficiencies. Method: information was obtained through review of the medical record, interview with the patient, photographic record of the diagnostic methods to which the patient was submitted and review of the literature. Conclusions: The reported case and published publications bring to light the discussion of the therapy of a complex situation that is the disease Pericardial Tuberculosis Rifampicin resistant in patients with lung cancer and showed that, despite the low simultaneous occurrence of the two diseases in question, in the same patient, satisfactory results from the treatment of Rifampicin-resistant Pericardial TB can be obtained by the treatment recommended by Informative Note N9/2021 -CGDR/DCCI/SVS/MS, in parallel with the treatment of lung cancer, in order to provide the patient with symptomatic relief, healing and improvement of their quality of life.
Ler mais

RIFAMPICIN-RESISTANT PERICARDIAL TUBERCULOSIS ASSOCIATED WITH LUNG CANCER

  • DOI: 10.22533/at.ed.15932123280310

  • Palavras-chave: Mycobacterium tuberculosis rifampicin. Pericardial tuberculosis, Lung cancer.

  • Keywords: Mycobacterium tuberculosis rifampicin. Pericardial tuberculosis, Lung cancer.

  • Abstract:

    Purpose: to report a case of Rifampicin-resistant Pericardial Tuberculosis with concomitant diagnosis of bronchogenic CA in a patient with no history of immunodeficiencies. Method: information was obtained through review of the medical record, interview with the patient, photographic record of the diagnostic methods to which the patient was submitted and review of the literature. Conclusions: The reported case and published publications bring to light the discussion of the therapy of a complex situation that is the disease Pericardial Tuberculosis Rifampicin resistant in patients with lung cancer and showed that, despite the low simultaneous occurrence of the two diseases in question, in the same patient, satisfactory results from the treatment of Rifampicin-resistant Pericardial TB can be obtained by the treatment recommended by Informative Note N9/2021 -CGDR/DCCI/SVS/MS, in parallel with the treatment of lung cancer, in order to provide the patient with symptomatic relief, healing and improvement of their quality of life.

  • PAULA FRANCIS GOMES VIANA RIBEIRO
  • SOLANGE DE MORAES MONTANHA
  • BRUNO HERINGER
  • FELIPE AMORIM ZAROUR
  • MAYANE EMANUELLE OLIVEIRA FONSECA
  • Madson Silva e Sousa
Fale conosco Whatsapp